Post-Traumatic Stress Disorder Market Overview

The post-traumatic stress disorder (PTSD) treatment market can expect to attain a growth rate of 4.8% during the evaluation period (between 2020 and 2027). The global market worth by the end of 2027 should be around USD 1,380 million, projects Market Research Future.

Post-Traumatic Stress Disorder Market or PTSD is a type of psychological condition, which has an impact on people regardless of their age or gender. Some of the key symptoms of PTSD arise almost immediately post the traumatic experience while others occur over a certain course of time. Some of the symptoms include mood swings, avoiding stressful situations, and more. The prevalence of the condition is statistically more among women. The higher rate of domestic and sexual abuse among the female population worldwide leads to the occurrence of the mental disorder.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8376

Post-Traumatic Stress Disorder Market Segmentation

The post-traumatic stress disorder industry has been considered for treatment, as well as end-userThe treatment-based segments highlighted in the review report are anti-anxiety medications, prazosin, medications, psychotherapy, and others.

Major end-users listed are ambulatory surgical centers, clinics, hospitals, home care, senior citizen centers, and more.

Post-Traumatic Stress Disorder Market Regional Analysis

North America has bagged the leading spot in the worldwide market for post-traumatic stress disorder treatment, given the drastic increase in the number of mental disorders arising from sexual molestation, childhood physical abuse, physical attack, combat exposure, rape, and childhood neglect.

Europe’s growing prominence in the global market is notable, with the region capturing the second place. The market size in the region has been blossoming on the back of the surge in human right issues such as sexual violence leaving long as well as a short-term impact on the mental health. The significant focus on research and development activities among major companies in the region further bolsters the market value.

As the fastest-progressing market, Asia Pacific benefits from the fast-emerging countries with booming population. China and India stand at the vanguard of the APAC market, thanks to the alarming rise in road accidents coupled with the surge in various traumatic events and more.

Post-Traumatic Stress Disorder Market Players

  • Mylan NV (US), Bionomics (Australia), GlaxoSmithKline (UK), Azevan Pharmaceuticals (US), Eli Lilly and Company (US), Tonix Pharmaceuticals Holding Corp. (US), Pfizer (US), Greenstone LLC (US), H. Lundbeck A/S (Denmark), Marinus Pharmaceuticals, Inc. (US) are the biggest post traumatic stress disorder treatment drugs and products manufacturers highlighted in the research study.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/post-traumatic-stress-disorder-market-8376

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com